Inhaled iloprost in preterm infants with severe respiratory distress syndrome and pulmonary hypertension

American Journal of Perinatology

Volumn 31, Issue 4, 2014, Pages 321-326

  Yilmaz, Osman ^a   Kahveci, Hasan ^b   Zeybek, Cenap ^a   Ciftel, Murat ^a   Kilic, Omer ^c  

^a Department of Pediatric Cardiology District Training and Research Hospital ^*  (Turkey)

^b Nene Hatun Gynecology and Obstetrics Hospital   (Turkey)

^c Erzurum District Training and Research Hospital   (Turkey)

Author keywords

aerosolized iloprost; nitric oxide; preterm infant; pulmonary hypertension

Indexed keywords

BERACTANT; HYPERTENSIVE FACTOR; ILOPROST; VASODILATOR AGENT;

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPOXEMIA; INFANT; LUNG ALVEOLUS OXYGEN TENSION; LUNG ARTERY PRESSURE; MALE; MEDICAL NEBULIZER; OUTCOME ASSESSMENT; OXYGEN SATURATION; OXYGENATION; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS SYNDROME; RETROSPECTIVE STUDY; SEPSIS; SYSTEMIC DISEASE; TREATMENT RESPONSE; COHORT ANALYSIS; COMPLICATION; INHALATIONAL DRUG ADMINISTRATION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PERSISTENT FETAL CIRCULATION SYNDROME; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; COHORT STUDIES; FEMALE; HUMANS; ILOPROST; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PERSISTENT FETAL CIRCULATION SYNDROME; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 84897954118     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0033-1348949     Document Type: Article

References (31)

1. Rudolph A. M. Fetal and neonatal pulmonary circulation. Annu Rev Physiol: 1979; 41 383 395
2. Whitsett J. A., Pryhuber G. S., Rice W. R., et al. Acute respiratory disorders. In: Avery G. B., Fletcher M. A., Macdonald M. G., eds. Neonatology: Pathophysiology and Management of the Newborn. 5th ed. Baltimore, MD Lippincott Williams and Wilkins: 1999; 497 501
3. Walther F. J., Benders M. J., Leighton J. O. Persistent pulmonary hypertension in premature neonates with severe respiratory distress syndrome. Pediatrics: 1992; 90 899 904
4. Yeh T. F. Persistent pulmonary hypertension in preterm infants with respiratory distress syndrome. Pediatr Pulmonol: 2001; 23 103 106
5. Ostrea E. M., Villanueva-Uy E. T., Natarajan G., Uy H. G. Persistent pulmonary hypertension of the newborn: pathogenesis, etiology, and management. Paediatr Drugs: 2006; 8 179 188 (Pubitemid 43927187)
6. Skinner J. R., Boys R. J., Hunter S., Hey E. N. Pulmonary and systemic arterial pressure in hyaline membrane disease. Arch Dis Child: 1992; 67 (Spec No): 366 373
7. De Jaegere A. P., van den Anker J. N. Endotracheal instillation of prostacyclin in preterm infants with persistent pulmonary hypertension. Eur Respir J: 1998; 12 932 934 (Pubitemid 28491670)
8. Dhillon R. The management of neonatal pulmonary hypertension. Arch Dis Child Fetal Neonatal Ed: 2012; 97 F223 F228
9. Ehlen M., Wiebe B. Iloprost in persistent pulmonary hypertension of the newborn. Cardiol Young: 2003; 13 361 363 (Pubitemid 41630876)
10. Roberts J. D. Jr, Fineman J. R., Morin F. C. III., et al. The Inhaled Nitric Oxide Study Group Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med: 1997; 336 605 610 (Pubitemid 27093405)
11. Walsh-Sukys M. C., Tyson J. E., Wright L. L., et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics: 2000; 105 1 Pt 1 14 20 (Pubitemid 30035712)
12. Van Meurs K. P., Wright L. L., Ehrenkranz R. A., et al. Preemie Inhaled Nitric Oxide Study Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med: 2005; 353 13 22 (Pubitemid 41007803)
13. Cole F. S., Alleyne C., Barks J. D., et al. NIH Consensus Development Conference statement: inhaled nitric-oxide therapy for premature infants. Pediatrics: 2011; 127 363 369
14. Bindl L., Fahnenstich H., Peukert U. Aerosolised prostacyclin for pulmonary hypertension in neonates. Arch Dis Child Fetal Neonatal Ed: 1994; 71 F214 F216
15. Kelly L. K., Porta N. F., Goodman D. M., Carroll C. L., Steinhorn R. H. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. J Pediatr: 2002; 141 830 832 (Pubitemid 35471646)
16. Lakshminrusimha S., Porta N. F., Farrow K. N., et al. Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn. Pediatr Crit Care Med: 2009; 10 106 112
17. Krause W., Krais T. Pharmacokinetics and pharmacodynamics of the prostacyclin analogue iloprost in man. Eur J Clin Pharmacol: 1986; 30 61 68 (Pubitemid 16166985)
18. Eifinger F., Sreeram N., Mehler K., Huenseler C., Kribs A., Roth B. Aerosolized iloprost in the treatment of pulmonary hypertension in extremely preterm infants: a pilot study. Klin Padiatr: 2008; 220 66 69 (Pubitemid 351518681)
19. Golan A., Zalzstein E., Zmora E., Shinwell E. S. Pulmonary hypertension in respiratory distress syndrome. Pediatr Pulmonol: 1995; 19 221 225
20. Tolsa J. F., Cotting J., Sekarski N., Payot M., Micheli J. L., Calame A. Magnesium sulphate as an alternative and safe treatment for severe persistent pulmonary hypertension of the newborn. Arch Dis Child Fetal Neonatal Ed: 1995; 72 F184 F187
21. Abu-Osba Y. K., Galal O., Manasra K., Rejjal A. Treatment of severe persistent pulmonary hypertension of the newborn with magnesium sulphate. Arch Dis Child: 1992; 67 (1 Spec No) 31 35
22. Boo N. Y., Rohana J., Yong S. C., Bilkis A. Z., Yong-Junina F. Inhaled nitric oxide and intravenous magnesium sulphate for the treatment of persistent pulmonary hypertension of the newborn. Singapore Med J: 2010; 51 144 150
23. Lipsitz P. J. The clinical and biochemical effects of excess magnesium in the newborn. Pediatrics: 1971; 47 501 509
24. Barrington K. J., Finer N. N. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev: 2001; 4 CD000509
25. Kumar V. H., Hutchison A. A., Lakshminrusimha S., Morin F. C. III, Wynn R. J., Ryan R. M. Characteristics of pulmonary hypertension in preterm neonates. J Perinatol: 2007; 27 214 219 (Pubitemid 46487712)
26. Stolar C. J., Snedecor S. M., Bartlett R. H. Extracorporeal membrane oxygenation and neonatal respiratory failure: experience from the extracorporeal life support organization. J Pediatr Surg: 1991; 26 563 571
27. Mulligan C., Beghetti M. Inhaled iloprost for the control of acute pulmonary hypertension in children: a systematic review. Pediatr Crit Care Med: 2012; 13 472 480
28. Soditt V., Aring C., Groneck P. Improvement of oxygenation induced by aerosolized prostacyclin in a preterm infant with persistent pulmonary hypertension of the newborn. Intensive Care Med: 1997; 23 1275 1278 (Pubitemid 28017795)
29. Piastra M., De Luca D., De Carolis M. P., et al. Nebulized iloprost and noninvasive respiratory support for impending hypoxaemic respiratory failure in formerly preterm infants: a case series. Pediatr Pulmonol: 2012; 47 757 762
30. Gürakan B., Kayiran P., Oztürk N., Kayiran S. M., Dindar A. Therapeutic combination of sildenafil and iloprost in a preterm neonate with pulmonary hypertension. Pediatr Pulmonol: 2011; 46 617 620
31. Tissot C., Beghetti M. Review of inhaled iloprost for the control of pulmonary artery hypertension in children. Vasc Health Risk Manag: 2009; 5 325 331